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Endometrial cancer remains the leading gynecolog-
ic cancer in the United States accounting for
32,800new cases in 2004 with 5900deaths [1].
Historically, treatment of endometrial cancer has
consisted of surgery combined with radiation on
chemotherapy for selected individuals with inter-
mediate or high-risk disease based on surgical
staging and histology. This has produced excellent
outcomes, but may also result in significant patient
morbidity. Laparoscopic techniques and equipment
have matured over the last 15years and are now
widely used to treat many endometrial cancers and
other gynecologic malignancies, thereby potential-
ly reducing postoperative morbidity while produc-
ing outcomes equivalent to those of laparotomy.
We will present an overview of the laparoscopic
approach to endometrial cancer, focusing on out-
comes, techniques and strategies to deal with some
of the challenges encountered with this patient
population.0020-7292/$ - see front matter D 2006 International Federation of
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Over 70% of new endometrial cancer cases are
diagnosed in postmenopausal women. The disease
is commonly associated with medical co-morbid-
ities such as diabetes, hypertension and obesity [2].
As a result, many women affected by endometrial
cancer are classified as high-risk surgical patients.
For patients presenting with disease that appears
to be confined to the uterus on initial examination,
treatment consists of total hysterectomy, bilateral
salpingo-oopherectomy, pelvic and para aortic
lymphadenectomy.
The primary endpoints of studies on laparoscopic
cancer staging are to demonstrate equivalence
with laparotomy with respect to completeness of
surgical staging while providing comparable surviv-
al rates. Table 1 lists the numerous published
reports demonstrating the adequacy of laparoscopy
for obtaining complete surgical staging specimens
in comparison with laparotomy data, presented in
Table 2. When compared to laparotomy, major
advantages of the laparoscopic approach include
faster healing, reduced postoperative ileus, less
pain, fewer adhesions, less blood loss and a better
view of upper abdominal organs, not to mention
equal or better numbers of lymph nodes retrievedInternational Journal of Gynecology and Obstetrics (2006) 93, 176—181Gynecology and Obstetrics. Published by Elsevier Ireland Ltd.
Table 1 Summary of publications on laparoscopy for endometrial cancer
N OR time EBL Nodes Days Convert
Boike et al. [27] 33 217 na 18.9 2.5 5.3%
Magrina et al. [28] 15 174 272 18.5 3.4 3.4%
Spirtos et al. [29] 13 na na 28 2.4 0
Holub et al. [30] 11 153 130 na 4.7 na
Moore et al. [31] 80 170 223 20.1 2.5 1.3%
Gemignani et al. [25] 69 214 211 7 2.9 3.0%
Scribner et al. [26] 19 237 350 34 3.7 0
Eltabbakh et al. [16] 40 195 318 11.3 2.5 2.5%
Holub et al. [9] 177 163 211 16.8 3.9 3.4%
Langebrekke et al. [11] 27 143 na 6.8 4.3 3.7%
Eltabbakh [10] 100 na 200 13.5 2.0 1.0%
Litta et al. [32] 29 186 125 14.2 2.5 0
Occelli et al. [33] 69 165 na 15.8 4.0 1.2%
Kuoppala et al. [12] 40 145 171 11.1 2.7 0
Unweighted average 180.2 16.6 3.1
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bidity leads to earlier recovery with shortened
hospital stays.
The first laparoscopic staging study reported
using the laparoscopically assisted vaginal hyster-
ectomy technique with lymphadenectomy to treat
clinical stage I endometrial cancer in 59women [6].
They were unable to perform a laparoscopic
lymphadenectomy in 6% of patients due to expo-
sure or body habitus, and had a 5% complication
rate. Many of the more recent studies show a
progressive decrease in the complication rate and
the percentage of patients unable to be staged
laparoscopically (see Table 1).
There are three published prospective series
comparing outcomes for laparoscopic versus staging
via laparotomy for endometrial cancer, one of which
is a prospective randomized clinical trial. In the
randomized trial, 63patients underwent laparosco-
py and 59patients underwent laparotomy for treat-
ment [7]. Disease-free survival and overall survival
were not significantly different in the two groupsTable 2 Summary of publications on laparotomy for endo
N OR time
Boike et al. [27] 37 194
Magrina et al. [28] 15 142
Spirtos et al. [29] 17 na
Holub et al. [30] 26 127
Moore et al. [31] 45 140
Gemignani et al. [25] 251 144
Scribner et al. [26] 17 157
Eltabbakh et al. [16] 86 na
Holub et al. [9] 44 115
Langebrekke et al. [11] 24 87
Eltabbakh [10] 40 na
Litta et al. [32] 30 152
Occelli et al. [33] 58 123
Kuoppala et al. [12] 40 96
Unweighted average 134.3but the power of the study is relatively low due to
the small size of the two treatment groups. In the
two prospective series and in two additional case—
control, retrospective series, disease-free survival
is not statistically different for the laparoscopy
versus laparotomy groups with 12—76months of
follow-up [8—12]. The patterns of recurrence are
similar in all five reports and no port-site metasta-
ses were recorded. There is as yet no large,
published, prospective, randomized trial comparing
laparotomy with laparoscopy in the management of
endometrial cancer. The Gynecologic Oncology
Group is conducting an ongoing Phase III randomized
trial comparing laparoscopic lymph node sampling
with vaginal hysterectomy and bilateral salpingo-
oopherectomy to laparotomy with lymph node
sampling, abdominal hysterectomy and bilateral
salpingo-oopherectomy in women with clinical
stage I and stage IIA endometrial adenocarcinoma.
The purpose of this study is to compare the
incidence of surgical complications, morbidity and
mortality, length of stay, quality of life and recur-metrial cancer
EBL Nodes Days
na 18.7 5
502 23.5 6.6
na 29 6.4
150 na 7.7
474 20.1 6.7
209 11.7 4.1
344 6 6.7
250 30 5.2
255 10.5 5.0
na 14.3 7.3
303 5.3 6.5
153 13.4 6.4
na 11.0 9.0
238 7.3 7.6
15.4 6.4
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will not be available for several years.3. Management of comorbidities
Obesity is a common condition in women with
endometrial cancer and this may complicate surgi-
cal treatment of the disease. Classifying obesity is
most commonly done by calculating body mass
index (BMI) and the severity of obesity is stratified
according to the BMI. Obesity is commonly defined
as a BMI of 30 or higher and extreme obesity as a
BMI of 40 or higher. Table 3 demonstrates a
classification system summarizing the guidelines
published by the National Heart, Lung, and Blood
Institute and the World Health Organization [13].
Waist circumference and waist/hip ratio (WHR)
are newer methods for assessing the severity of a
patient’s obesity. Waist circumference has been
positively correlated with abdominal fat content.
However, when evaluating a patient for fat distri-
bution the waist/hip ratio seems to be of greater
relevance. A WHR of greater than 0.85 indicates
android or abdominal obesity. These patients have
adipose tissue that is mainly distributed over supra-
umbilical areas, trunk, and arms [14]. Use of the
WHR is very helpful for planning laparoscopic
surgery.
Induction, maintenance of sedation, and waking
obese patients can be a challenge, not to mention
post-operative risk of atelectasis, pneumonia, deep
venous thrombosis, pulmonary embolus, ileus, and
wound infection. These risks have also been shown
to be increased with more extensive laparotomy
procedures, often leading to slower return of bowel
function, prolonged immobilization, and longer
hospital stays [15].
Laparoscopy provides an alternative to laparot-
omy for a number of surgical procedures in obese
patients that may result in fewer operative com-
plications, shorter hospital stays, and more rapid
recoveries. It has recently been shown that lapa-
roscopy is feasible in the obese patient. Eltabbakh
et al. reported on 42women with clinical stage ITable 3 National heart, lung, and blood institute
and the World Health organization classification
system for obesity [13]
Description Class BMI
Normal weight 18.5—24.9
Overweight 25.0—29.9
Obesity I 30.0—34.9
Obesity II 35.0—39.9
Extreme obesity III z40endometrial cancer and a body mass index (BMI) of
greater than 28.0 who were offered laparoscopic
staging and compared to matched controls that
underwent laparotomy [16]. The mean BMI was
35.8, but conversion to laparotomy occurred in only
7.5% of patients. There was no difference in
surgical complications, total cost per case, postop-
erative pain perception or patient satisfaction.
Women undergoing laparoscopy had a greater
number of lymph nodes retrieved, less blood loss,
decreased pain medication requirements, shorter
hospital stays, but operative time was significantly
longer.
Multiple studies suggest that laparoscopy in the
elderly is also safe, feasible and has similar out-
comes to the same procedures in a younger patient
population. Scribner et al. evaluated elderly
patients for their ability to withstand laparoscopic
surgery in a retrospective study of 125women with
endometrial cancer [17]. 67patients underwent
planned laparoscopic staging and they were com-
pared with 45patients who underwent laparotomy
and 13patients who underwent vaginal hysterecto-
my. Of the patients who underwent laparoscopic
staging, the procedure was completed in 77.6% of
the patients but could not be performed in 10.4%
secondary to obesity. When compared with the
women who had staging at laparotomy, the elderly
patients who underwent laparoscopy had signifi-
cantly shorter hospital stays, fewer postoperative
fevers, lower likelihood of postoperative ileus and
fewer wound complications.4. Other outcome measures
Quality of life outcome measures for obese patients
were compared in a study of laparoscopic staging
and laparotomy staging [16]. Patients in the two
groups reported equal satisfaction. The laparoscop-
ic staging group resumed full activities in 23days on
average, in comparison with 45days for patients
who underwent laparotomy. Return to work was
correspondingly shorter in the laparoscopy group
compared to the laparotomy group, with an
average of 35 and 67days, respectively.
The use of uterine manipulators during laparo-
scopic staging procedures has been postulated to
increase the risk of positive intraperitoneal cytol-
ogy by causing extrusion of endometrial tissue
through patent Fallopian tubes. The incidence of
this problem and the prognostic significance of
positive peritoneal washings in this setting is not
clear [18]. To address this concern, Eltabbakh et al.
recently completed a prospective study that in-
cluded 42women undergoing laparoscopic surgery
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intrauterine use of the Pelosi uterine manipulator
did not increase the incidence of malignant peri-
toneal cytology among women with early stage
endometrial cancer. No patients had positive wash-
ings after the insertion of the manipulator if the
washings were initially negative [19]. Based on this
single study, it is likely that laparoscopic surgery
probably does not significantly increase the chance
of positive peritoneal cytology. Until more data are
available, it is prudent to seal the Fallopian tubes
before the insertion of the uterine manipulator.
This technique should minimize the risk of iatro-
genic peritoneal spread.Table 4 Cost comparison for laparoscopy versus
laparotomy for gynecologic cancer staging procedures
Laparoscopy Laparotomy
Spirtos et al. [24] 13,809 17,119
Gemignani et al. [25] 11,826 15,189
Scribner et al. [26] 5198 5331
Eltabbakh et al. [16] 13,003 11,878
Values expressed in US $.5. Laparoscopic staging technique in
endometrial cancer
Surgical approaches utilized in the laparoscopic
staging of endometrial cancer include the laparo-
scopic-assisted vaginal hysterectomy (LAVH), total
laparoscopic hysterectomy (TLH), and the use of
robot-assisted laparoscopy using the daVinciR sur-
gical system (Intuitive Surgical). The latter two
approaches are favored at the author’s institution.
The patient is placed in the dorsal lithotomy
position with arms tucked at the sides and using
both padded stirrups and padded shoulder braces.
Typically, four radial-dilating ports are placed. The
radial dilating ports have an improved safety
profile over older cutting-type ports [20]. After
pneumoperitoneum is obtained, a uterine manipu-
lator such as the ZUMIR (Cooper Surgical) is placed
in conjunction with a KohR colpotomy (Cooper
Surgical) ring and a vaginal pneumo-occluder
balloon. Peritoneal cytology is collected first.
Performing the para-aortic node dissection early
in the case is easiest because the bowel tends to be
least likely to be distended with gas or to be
edematous. Moreover, leaving the peritoneal at-
tachment of the descending colon attached to the
left pericolic gutter aids exposure of the para-
aortic nodes. This attachment is divided later to
expose the pelvic nodes, which would lessen the
exposure of the para-aortic nodes if done first.
Para-aortic and pelvic lymphadenectomy is per-
formed utilizing a microprossessor-controlled, bi-
polar vessel sealer that can be used for grasping,
traction, dissection, vessel sealing and cutting,
thereby greatly reducing the number of times an
instrument needs to be changed in order to
complete the dissection. In the author’s institution,
we use the Gyrus Plasmakinetic SystemR cutting
forceps for this function, although there are 3
commercial products available with similar fea-tures. These include the Gyrus product in addition
to LigaSure (Valleylab) and EnSeal (SurgRx). All
three are approved for sealing vessels up to 7mm in
diameter with burst strength exceeding 300mmHg
and with 1—3mm of lateral thermal spread. Once
the lymphadenectomy is complete, the hysterec-
tomy and bilateral salpingo-oophorectomy is com-
pleted laparoscopically using the microprocessor-
controlled, bipolar vessel sealer to seal and divide
the ovarian and uterine vessels. A colpotomy
incision is made using a monopolar hook with
electrosurgical cutting current onto the underlying
colpotomy ring previously placed in the vagina.
After the specimen is removed via the vagina, the
vaginal cuff is sutured laparoscopically either with
conventional suture or with a laparoscopic suturing
device such as the Endo StitchR (United States
Surgical).
The daVinciR surgical system is an innovative
technology that addresses many of the current
limitations of laparoscopy, including development
of a three-dimensional vision system for the
surgeon, and laparoscopic instruments with a
wrist-like mechanism allowing full replication of
the range of motion of the surgeon’s hand with an
8mm instrument. The daVinciR surgical system was
profiled in the lead article of this Surgery and
Technology series and a recent publication from
this institution demonstrated the feasibility of
using robot-assisted laparoscopic staging for gyne-
cologic malignancies [21,22].6. Cost analysis and training
Laparoscopic staging procedures are complex and
the time and effort necessary for a surgeon to
master the necessary skills is substantial. A study
evaluating the learning curve for laparoscopic
endometrial cancer staging demonstrated that
operating time and rate of complications fell as
experience increased [23]. Moreover, the number
of lymph nodes removed during the lymphade-
nectomy rose substantially as experience in-
creased. Commitment on the part of surgeons
and the health care systems in which they work
A.S. Kueck et al.180is a necessary prelude to developing this exper-
tise. As would be expected, treatment-related
cost is increased early in the experience of a
laparoscopic surgeon. Four authors have pub-
lished data comparing cost for treatment of
endometrial cancer by experienced surgeons
[16,24—26]. In Table 4, data from the four series
shows that laparoscopic staging was less expen-
sive than laparotomy in three of the four studies.
Given the need to optimize care within the
budget constraints of health care systems around
the world, careful, ongoing analysis of cost—
benefit ratios including impact on quality of life
and return to productive work will be necessary.7. Conclusion
Laparoscopic staging of endometrial cancer has
been shown to be feasible and safe. Multiple
studies have demonstrated equivalence of laparo-
scopic staging in comparison to traditional laparot-
omy. A definitive, large, prospective, randomized
clinical trial to confirm the smaller studies cur-
rently in the literature is in progress but results are
likely to be several years in the future.References
[1] Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thum MJ.
Cancer statistics 2003. CA Cancer J Clin 2003 (Jan.—
Feb.);53(1):5 –26.
[2] Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and
trends in obesity among US adults, 1999—2000. JAMA
2002;288:1723–7.
[3] Eltabbakh GH, Shamonki MI, Moody JM, Garafano LL.
Laparoscopy as the primary modality for the treatment of
women with endometrial carcinoma. Cancer 2001;91(2):
378–87.
[4] Childers JM, Spirtos NM, Brainard P, Surwit EA. Laparoscopic
staging of the patient with incompletely staged early
adenocarcinoma of the endometrium. Obstet Gynecol
1994;83:597–600.
[5] Boike GM, Sciarra JJ. Laparoscopic management of uterine
malignancy. Gynecol Int 1996;5(4):108–12.
[6] Childers JM, Brzechffa PR, Hatch KD, Surwit EA. Laparos-
copically assisted surgical staging (LASS) of endometrial.
Gynecol Oncol 1993;51:33–8.
[7] Tozzi R, Malur S, Koehler C, Schneider A. Laparoscopy
versus laparotomy in endometrial cancer: first analysis of
survival of a randomized prospective study. J Minim Invasive
Gynecol 2005;12:130–6.
[8] Malur S, Possover M, Michaels W, Schneider A. Laparoscop-
ic-assisted vaginal versus abdominal surgery in patients
with endometrial cancer: a prospective randomized trial.
Gynecol Oncol 2001;80:239–44.
[9] Holub Z, Jabor A, Bartos P, et al. Laparoscopic surgery for
endometrial cancer: long-term results of a multicentric
study. Eur J Gynaecol Oncol 2002;23:305–10.[10] Eltabbakh GH. Analysis of survival after laparoscopy in
womenwith endometrial cancer. Cancer 2002;95:1894–901.
[11] Langebrekke A, Istre O, Hallquist AC, et al. Comparison of
laparoscopy and laparotomy in patients with endometrial
cancer. J Am Assoc Gynecol Laparosc 2002;9:152–7.
[12] Kuoppala T, Tomas E, Heinonen PK. Clinical outcome and
complications of laparoscopic surgery compared with
traditional surgery in women with endometrial cancer. Arch
Gynecol Obstet 2004;270:25–30.
[13] National Heart, Lung, and Blood Institute. Clinical guide-
lines on the identification, evaluation, and treatment of
overweight and obesity in adults. Available at http://
www.nhlbi.nih.gov/guidelines/index.htm.
[14] Bongain A, Isnard V, Gillet JY. Obesity in obstetrics and
gynecology. Eur J Obstet Gynecol Reprod Biol 1998;77:
217–28.
[15] Scribner DR, Walker JL, Johnson GA, McMeekin DS, Gold MA,
Mannel RS. Laparoscopic pelvic and paraaortic lymph node
dissection in the obese. Gynecol Oncol 2002;84:426–30.
[16] Eltabbakh GH, Shamonki MI, Moody JM, Garafano LL.
Hysterectomy for obese women with endometrial cancer:
laparoscopy or laparotomy? Gynecol Oncol 2000;78(3 Pt 1):
329–35.
[17] Scribner DR, Walker JL, Johnson GA, McKeekin SD, Gold MA,
Mannel RS. Surgical management of early-stage endome-
trial cancer in the elderly: is laparoscopy feasible? Gynecol
Oncol 2001;83(3):563–8.
[18] Sonoda Y, Zerbe M, Smith A, Lin O, Barakat RR, Hoskins
WJ. High incidence of positive peritoneal cytology in low-
risk endometrial cancer treated by laparoscopicallly
assisted vaginal hysterectomy. Gynecol Oncol 2001;80:
378–82.
[19] Eltabbakh GH, MOunt SL. Laparoscopic surgery does not
increase the positive peritoneal cytology among women
with endometrial carcinoma. Gynecol Oncol 2006;100:
361–4.
[20] Rubenstein JN, Blunt LW, Lin WW, User HM, Nadler RB,
Gonzalez CM. Safety and efficacy of 12-mm radial dilating
ports for laparoscopic access. BJU 2003;92:327–9.
[21] Senapati S, Advincula AP. Telemedicine and robotics: paving
the way to the globalization of surgery. Int J Gynecol Obstet
2005;91:210–6.
[22] Reynolds RK, Burke WM, Advincula AP. Preliminary experi-
ence with robot-assisted laparoscopic staging of gyneco-
logic malignancies. JSLS 2005;9:149–58.
[23] Holub Z, Jabor A, Bartos P, Hendl J, Urbanek S. Laparo-
scopic surgery in women with endometrial cancer: the
learning curve. Eur J Obstet Gynecol Reprod Biol 2003;
107(2):195–200.
[24] Spirtos NM, Schlaerth JB, Gross GM, Spirtos TW, Schlaerth
SC, Ballon SC. Cost and quality-of-life analyses of surgery
for early endometrial cancer: laparotomy versus laparos-
copy. Am J Obstet Gynecol 1996 (Jun.);174(6):1795–9.
[25] Gemignani ML, Curtini JP, Zelmanovich J, et al. Laparo-
scopic-assisted vaginal hysterectomy for endometrial can-
cer: clinical outcomes and hospital charges. Gynecol Oncol
1999;73:5–11.
[26] Scribner DR, Mannel RD, Walker JL, Johnson GA. Cost
analysis of laparoscopy vs laparotomy for early endometrial
cancer. Gynecol Oncol 1999;75:46–463.
[27] Boike G, Lurain J, Burke J. A comparison of laparoscopic
management of endometrial cancer with traditional lapa-
rotomy. Gynecol Oncol 1994;52:105.
[28] Magrina JF, Serrano L, Cornella JL. Laparoscopic lympha-
denectomy and radical or modified radival vaginal hyster-
ectomy for endometrial and cervical carcinoma:
preliminary experience. J Gynecol Surg 1995;11:147–51.
Laparoscopic technology for the treatment of endometrial cancer 181[29] Spirtos NM, Schlaerth JB, Spirtos TW, et al. Laparoscopic
bilateral pelvic and paraaortic lymph node sampling: an
evolving technique. Am J Obstet Gynecol 1995;173:105–11.
[30] Holub Z, Voracek J, Shomani A. A comparison of laparoscoic
surgery with open procedure in endometrial cancer. Eur J
Gynaecol Oncol 1998;19:294–6.
[31] Moore J, Hatch KD, Hallum III AV, Magdy N. Comparison of
laparoscopic assisted vaginal hysterectomy with total ab-
dominal hysterectomy for the management of endometrialcancer. [Abstract]. 30th Annual Meeting of the Society of
Gynecologic Oncologists; 20—24 March, San Francisco, CA.
[32] Litta P, Fracas M, Possan C, et al. Laparoscopic management
of early stage endometrial cancer. Eur J Gynaecol Oncol
2003;24:41–4.
[33] Occeli B, Samouelian V, Narducci F, et al. The choice of
approach in the surgical management of endometrial
carcinoma: a retrospective series of 155 cases. Bull Cancer
2003;90:347–55.
